Tomas Blomquist
Director/Board Member at NOLATO AB
Net worth: 495 757 $ as of 30/03/2024
Tomas Blomquist active positions
Companies | Position | Start | End |
---|---|---|---|
NOLATO AB | Director/Board Member | 31/12/2020 | - |
Career history of Tomas Blomquist
Former positions of Tomas Blomquist
Companies | Position | Start | End |
---|---|---|---|
BIOTAGE AB | Chief Executive Officer | 05/11/2019 | 03/01/2024 |
President | 05/11/2019 | 03/01/2024 | |
Abbott Rapid Diagnostics Ltd.
Abbott Rapid Diagnostics Ltd. Miscellaneous Commercial ServicesCommercial Services Abbott Rapid Diagnostics Ltd. provides global diagnostics and health management services. It offers diagnostic products and health screening services for healthcare providers to perform diagnostic testing in clinics, communities, hospitals, or homes and rapid diagnostics solutions for cardiovascular disease, infectious disease, drugs of abuse, oncology and women's health. The firm provides products and solutions in the areas of biochemistry, cardiology, community nursing, critical care, diabetes, emergency medicine, general practice, microbiology, NHS health check, pharmacy, primary care, research and women's health services. The company is headquartered in Stockport, United Kingdom. | Director/Board Member | 22/09/2015 | 25/08/2019 |
Statistics
International
Sweden | 3 |
United Kingdom | 2 |
Operational
Director/Board Member | 2 |
Chief Executive Officer | 1 |
President | 1 |
Sectoral
Electronic Technology | 2 |
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
NOLATO AB | Electronic Technology |
BIOTAGE AB | Health Technology |
Private companies | 1 |
---|---|
Abbott Rapid Diagnostics Ltd.
Abbott Rapid Diagnostics Ltd. Miscellaneous Commercial ServicesCommercial Services Abbott Rapid Diagnostics Ltd. provides global diagnostics and health management services. It offers diagnostic products and health screening services for healthcare providers to perform diagnostic testing in clinics, communities, hospitals, or homes and rapid diagnostics solutions for cardiovascular disease, infectious disease, drugs of abuse, oncology and women's health. The firm provides products and solutions in the areas of biochemistry, cardiology, community nursing, critical care, diabetes, emergency medicine, general practice, microbiology, NHS health check, pharmacy, primary care, research and women's health services. The company is headquartered in Stockport, United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Tomas Blomquist
- Experience